Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 2
1977 4
1978 5
1979 4
1980 8
1981 5
1982 2
1983 4
1984 3
1985 2
1986 5
1987 9
1988 7
1989 9
1990 8
1991 9
1992 11
1993 14
1994 9
1995 18
1996 26
1997 18
1998 18
1999 27
2000 13
2001 12
2002 21
2003 17
2004 13
2005 15
2006 17
2007 30
2008 44
2009 37
2010 42
2011 26
2012 18
2013 7
2014 12
2015 3
2016 8
2017 7
2018 3
2019 3
2020 1
2021 4
2022 3
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

550 results

Results by year

Filters applied: . Clear all
Page 1
CAR-T cell therapy in myeloma: hopes and hurdles.
Harousseau JL. Harousseau JL. Blood Sci. 2023 Jan 4;5(2):136-137. doi: 10.1097/BS9.0000000000000148. eCollection 2023 Apr. Blood Sci. 2023. PMID: 37228772 Free PMC article. No abstract available.
Current Advances in Multiple Myeloma: A Post International Myeloma Society (IMS 2022) Round Table Debate by the International Academy for Clinical Hematology (IACH).
Bahlis NJ, Costa LJ, Facon T, Harousseau JL, Manier S, Perrot A, Touzeau C, Mohty M. Bahlis NJ, et al. Among authors: harousseau jl. Clin Hematol Int. 2023 Jun;5(2-3):112-121. doi: 10.1007/s44228-023-00036-8. Epub 2023 Apr 15. Clin Hematol Int. 2023. PMID: 37060392 Free PMC article. Review.
Sequencing anti-BCMA therapies in myeloma.
Harousseau JL, Mohty M. Harousseau JL, et al. Blood. 2023 Jan 19;141(3):211-212. doi: 10.1182/blood.2022018157. Blood. 2023. PMID: 36656612 Free article. No abstract available.
Beyond medicines' barriers: exploring the true cost of multiple myeloma.
Choon-Quinones M, Zelei T, Barnett M, Keown P, Durie B, Kaló Z, Almási T, Harousseau JL, Hose D. Choon-Quinones M, et al. Among authors: harousseau jl. J Med Econ. 2022 Jan-Dec;25(1):1167-1175. doi: 10.1080/13696998.2022.2133823. J Med Econ. 2022. PMID: 36397678 Free article. Review.
Requirements for operational cure in multiple myeloma.
Mohty M, Avet-Loiseau H, Harousseau JL. Mohty M, et al. Among authors: harousseau jl. Blood. 2021 Oct 21;138(16):1406-1411. doi: 10.1182/blood.2021012854. Blood. 2021. PMID: 34324647 Free article.
Up-front ixazomib in older patients with myeloma.
Harousseau JL, Mohty M. Harousseau JL, et al. Blood. 2021 Jul 1;137(26):3584-3586. doi: 10.1182/blood.2021011262. Blood. 2021. PMID: 34196682 Free article. No abstract available.
550 results